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Abstract:  The  aim  of  the  present  study  was  to  examine  the  potential  role  and  applicability  of  dietary
supplements in reducing the risk of development of amyloid diseases associated with the gastrointestinal tract,
such as type II diabetes. Trypsin, a well-known serine protease was used as a model protein in our experiments.
The effect  of  various red wines on the formation of  amyloid-like fibrils  of trypsin  was studied  in vitro,  in
aqueous  ethanol,  at  pH 7.0.  Turbidity  measurements,  aggregation  kinetics  experiments,  Congo  red  binding
assays  and  electronic  circular  dichroism  spectroscopic  measurements  were  used  to  follow  the  aggregation
process in the presence or absence of various red wines. The results suggest that red wines effectively inhibit the
formation of amyloid-like fibrils of trypsin and the inhibitory effect is dose-dependent. The extent of inhibition
was found to be proportional to the total concentration of phenolic compounds. 
Keywords:  Amyloid-like  fibrils;  Electronic  circular  dichroism;  Congo  red;  Natural  polyphenols;  Red wine;
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1. INTRODUCTION
Amyloid formation might be a general property of the polypeptide backbone as all proteins can form
long-unbranched,  β-sheet  rich amyloid fibrils  in vitro under appropriate conditions [1–2]. There are striking
similarities  in  the  aggregation  behaviour  of  different  peptides  and  proteins. Unfolded  or  partially unfolded
proteins  associate  with  each  other  to  form  small,  soluble  aggregates  that  undergo  further  assembly  into
protofibrils or protofilaments. These structures are commonly short, thin, sometimes curved, fibrillar species that
are presumed to assemble into mature fibrils. Experiments in vitro indicate that the formation of such species is
generally characterized by a lag phase, followed by a period of rapid growth. This phenomenon is associated
increasingly  with  common  and  highly  debilitating  diseases.  An  increasing  number  of  disorders,  including
Alzheimer's and Parkinson's diseases, spongiform encephalopathy and type II diabetes, are directly associated
with the deposition of such aggregates in brain, heart and spleen tissue. Amyloid diseases predominantly involve
the aggregation of specific proteins, such as the prion protein or the amyloid -peptide, but fibrils can be formed
by many other peptides and proteins [3]. Natural phenolic compounds, a long family of plant substances, are one
of  the  most  actively  investigated  categories  of  potential  amyloid  inhibitors  [4–6].  More  than  8,000  plant
polyphenols are currently known and more than 4,000 flavonoids have been identified among them [7]. Red
wine  represents  a  rich  source  of  polyphenols  such  as  flavonoids  (flavanol  monomers,  condensed  tannins,
flavonols, anthocyanins) and non-flavonoids (hydroxycinnamates, benzoic acids, hydrolyzable tannins, stilbenes
(resveratrol))  [8].  Resveratrol,  a  polyphenolic  red wine constituent,  inhibits  A42 fibril  formation and islet
amyloid polypeptide aggregation in a dose-dependent manner [9-10]. The inhibitory effect of flavone derivatives
is dependent on the number and position of hydroxyl groups around the flavone backbone [11]. The position of
phenolic hydroxyl moieties on the aromatic rings is a major determinant potent anti-aggregation effect, while the
number of hydroxyl groups is less important [12]. Natural phenolic and polyphenolic substances stabilize native
states, or remodel and inactivate toxic amyloid oligomers [4]. Several observations suggest that polyphenols
inhibit  amyloid  fibril  formation  through  specific  aromatic  interactions  with  the  amyloidogenic  core  [13].
Aromatic rings of polyphenolic compounds and the aromatic residues present in proteins may associate via -
stacking  interactions  [14].  The  hydrophobic  and/or  aromatic  character  of  these  compounds  contributes
significantly  to  the  anti-amyloidogenic  effect,  whereas  the  antioxidative  potency  relates  mostly  to  the
destabilization  of  fibrils  [15].  Studies  have  shown  that  the  presence  of  vicinal  dihydroxyphenyl  moieties,
irrespective of their position in the aromatic rings, play a key role in the inhibitory property of polyphenols [16–
17]. Non-flavonoids showed higher anti-aggregation activity than flavonoids. Polyphenols containing a higher
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number of aromatic rings, hydroxyl and keto groups and possess a high degree of planarity, have the largest
inhibition  activity [18]. A structure–function  relationship  study suggested  that  the  presence  of  at  least  two
phenolic rings with two to six atoms long linkers, along with a minimum number of three hydroxyl groups on the
aromatic rings, are essential for efficient inhibition exerted by polyphenols [5]. The mechanism of inhibition of
amyloid formation is not the same for all natural polyphenols. Some inhibit the formation of oligomers, but
promote fibril formation, others inhibit the formation of fibrils, but not oligomers, and there are others, which
inhibit both. Other polyphenols redirect amyloid fibrils from fibrillogenic forms to nonfibrillogenic oligomers
[19]. Polyphenols induce conformational changes in the oligomer aggregate. These changes disrupt H-bonds and
perturb the amyloid aggregate.  Polyphenol molecules push the β-sheets apart, which leads to a loosely packed
structure.  H-bonding  capacity  of  polyphenols  is  responsible  for  this  behavior  [20].  Flavonoids,  phenols  in
particular, represent an important component of a normal human diet. Elevated intake of dietary polyphenols
might be relevant to the prevention of amyloidosis. Nutraceutical strategies might become a way to reduce the
risk of certain amyloid diseases [19, 21]. Many drugs used today are natural products or derivatives of natural
products [22–23].
 Earlier  we have demonstrated  that  phenylmethylsulfonyl-trypsin  (PMS-trypsin)  forms  amyloid-like
fibrils in 60% (v/v) ethanol/10 mM phosphate buffer (PBS) at pH = 7.0 [24]. Here, we report that various red
wines inhibit the formation of amyloid-like fibrils of PMS-trypsin dose-dependently. 
2. MATERIALS AND METHODS 
2.1. Materials
Bovine pancreas trypsin (EC 3.4.21.4), gallic acid and N-benzoyl-L-arginine ethyl ester (BAEE) were
purchased  from  Sigma-Aldrich  Company  (Budapest,  Hungary).  Folin–Ciocalteu’s  phenol  reagent  was  the
product of Merck (Darmstadt, Germany).  Red wines were purchased from commercially sources:  La Bonita
Cabernet  Franc semi-sweet and  Pincegyöngye  Édes Vörös sweet red wines bottled by Helibor Ltd.,  H-6070
Izsák; Transdanubian Merlot sweet red wine, bottled by Szent Imre Wine-cellar Ltd., H-6223 Soltszentimre; La
Fiesta Kékfrankos semi-sweet red wine, bottled by Grape-Vine Ltd., H-6120 Kiskunmajsa; Egri bikavér 2012
dry red wine,  bottled by Ostoros-Novaj Bor Co., H-3327 Novaj;  Portugieser  2014 dry red wine, bottled by
Dolium Wine-cellar Ltd., H-7773 Villány.
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2.2. General methods
Trypsin concentration was determined based on the UV absorbance of the constituent aromatic and
cystine residues at 280 nm, using a calibration curve measured for trypsin in the 0-1 mg/ml concentration range.
Spectroscopic  samples  have  been  corrected  for  respective  solvent  backgrounds  in  all  experiments  where
applicable.
2.3. Assay of enzyme activity
Trypsin activity, with BAEE as a substrate, was determined using the method of Schwert and Takenaka
[25]. The absorption increase at 253 nm was measured in a 3 ml reaction mixture, containing 46.7 mM Tris/HCl
(pH 8.0) and 0.9 mM BAEE. The reaction was started by the addition of 20 l enzyme sample (0.15 mg/ml). 
2.4. Trypsin modification with phenylmethylsulfonyl fluoride (PMSF)
Chemical modification with PMSF inactivates trypsin irreversibly. Thus the autolysis of enzyme at pH
= 7.0 does not affect the experiments. Solutions of 8.4 l PMSF (100 mM) in 2-propanol and 20 l trypsin (50
mg/ml) in 0.001 M HCl were added to  2 ml 0.05 M PBS (pH = 7.0) at 24  oC while the solution was stirred.
During the procedure the same amounts of reactants were added four times, repeatedly to the solution.  The
enzyme sample was incubated for 30 min. The reaction mixture was then filtered on a Sephadex G-25 column in
0.05 M PBS (pH = 7.0), to remove the unreacted inhibitor molecules. The degree of conversion was determined
by enzymatic activity assays, of which results indicated that 95% of the trypsin had been modified.
2.5. Turbidity measurements
In order to estimate the amount of fibrillar material, turbidity of PMS-trypsin solutions was monitored
by UV-vis spectrophotometry at 350 nm and 24  oC, using a quartz cuvette of 10 mm path length. Turbidity
experiments were performed in 0.13 mg/ml solutions of PMS-trypsin in 60% (v/v) ethanol/10 mM PBS (pH =
7.0) after 24 h incubation in the presence or absence of red wines at a 50-fold final dilution. 
2.6. Determination of total phenolic content
The total phenolic content of red wine samples was determined utilizing the Folin-Ciocalteu reagent and
the  spectrophotometric  method  of  Waterhouse  [26].  For  calibration,  gallic  acid  solutions  of  different
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concentrations (0–50 mg/l) were used. The total phenolic content was expressed as mg gallic acid equivalents
(GAE) per l of red wine. The data presented are the average of three measurements.
2.7. Aggregation kinetics
Aggregation experiments were performed in 60% (v/v) ethanol/10 mM PBS (pH = 7.0) at 0.13 mg/ml
PMS-trypsin concentration and various concentrations of red wine. The increase of UV absorption at 350 nm,
indicative of the presence of large aggregated particles, was followed for 30 min at 24 oC and pH 7.0. 
2.8. CR binding
Absorption spectra of Congo red (CR) were recorded in the range of 400–600 nm using a 10 mm path
length quartz cuvette. Samples were prepared at a protein concentration of 0.285 mg/ml. 200  l  1-day-aged
PMS-trypsin samples in 60% (v/v) ethanol, in the absence or presence of Egri bikavér, were vortexed with 800
l of a solution, which contained 4.9 M CR, 5 mM PBS and 150 mM NaCl (pH 7.0) and incubated at room
temperature for 15 min before the measurements. Difference spectra were obtained by subtracting the spectra of
CR alone and PMS-trypsin alone from spectra of solutions containing both PMS-trypsin and CR.
2.9. ECD measurements
Electronic  circular  dichroism  (ECD)  measurements  were  carried  out  using  a  Jasco  J-815
spectropolarimeter.  Spectra were recorded in the range of 185–260 nm in a 1 mm path length cell at 24  oC.
PMS-trypsin was dissolved in 60% (v/v) ethanol/10 mM PBS (pH 7.0) at a concentration of 0.15 mg/ml. Red
wine was contained in the samples at a 50-fold dilution. Ellipticity was expressed in mdeg units.
3. RESULTS AND DISCUSSIONS
PMS-trypsin amyloid-like fibrils were prepared in aqueous ethanol according to our previous report
[24]. To determine whether red wines affect fibril formation of PMS-trypsin, samples were incubated in aqueous
ethanol  at  pH 7.0,  in  the presence  and absence  of  different  red wines.  Aggregation  of PMS-trypsin  can  be
monitored by turbidity measurements. An increase in the UV absorbance at 350 nm indicates a greater degree of
aggregation due to an increase in the scattering of light by aggregated particles [16]. In the absence of red wines,
higher absorbance values were observed indicating higher degree of  turbidity and that red wines have the ability
to effectively inhibit PMS-trypsin fibril formation in vitro (Figure 1). These experiments revealed that the 
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Figure 1. Turbidity changes of PMS-trypsin at 24 oC in 60% (v/v) ethanol/10 mM PBS (pH = 7.0), monitored
via the absorption at 350 nm after incubation for 24 h in the presence of various red wines at 50-fold dilution.
The protein concentration was 0.13 mg/ml.
Figure 2. Inhibition  of  amyloid-like  fibril  formation as  a  function  of  total  phenolic  content.  Percentage  of
inhibition in 60% (v/v) ethanol (●), total phenolic content (○). Red wines were diluted 50-fold in 60% (v/v)
ethanol/10 mM PBS (pH = 7.0). The protein concentration was 0.13 mg/ml. 
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greatest effect  was exerted by the red wine Egri  bikavér in 60% (v/v) ethanol/10 mM PBS (pH = 7.0). The
absorption at  350 nm decreased  to  51.9% relative to the reference  sample after  incubation for  24 h in the
presence of diluted Egri bikavér.
The total concentration of phenolic compounds of various red wines varied from 1,053 to 2,354 mg
GAE/l (Figure 2). The degree of inhibition was found to be proportional to the total phenolic content. Figure 3
illustrates that red wine led to a dose-dependent decrease in the absorption.
CR is a planar, hydrophobic, diazo dye, which binds to the β-sheet of amyloid and amyloid-like fibrils
selectively, therefore it is a commonly used agent to detect amyloid fibrils. Binding of CR to amyloid generally
results in an increase and a characteristic red shift (from 490 nm to 540 nm) of light absorption [27–28]. A
moderate red shift of the absorption maximum (from 490 nm to 510 nm) was observed in the visible spectra of
CR in the presence of PMS-trypsin in 60% (v/v) ethanol/10 mM PBS (pH = 7.0) (Figure 4).  Difference spectra
indicate spectral changes of CR upon binding to PMS-trypsin amyloid fibrils in the absence or presence of 25 to
250-fold diluted red wine, Egri bikavér. This suggests that the aggregates have amyloid-like properties in 60%
(v/v) ethanol/10 mM PBS (pH = 7.0) and the active components of Egri bikavér inhibit the formation of amyloid
fibrils dose-dependently.
Figure 3. Kinetics of aggregation of PMS-trypsin without red wine () in 60% (v/v) ethanol/10 mM PBS (pH =
7.0), or in the presence of Merlot wine diluted 50- (∆), 1000- (○), or 4000-fold (x), monitored via the time-
dependent increase of UV absorption at 350 nm, at 0.13 mg/ml protein concentration.
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Figure 4. Visible absorption spectra of PMS-trypsin stained with CR in 60% (v/v) ethanol/10 mM PBS (pH =
7.0): PMS-trypsin + CR (A, solid line), CR alone (A, dashed line), PMS-trypsin alone (A, dotted line) and differ-
ence spectra in 60% (v/v) ethanol/10 mM PBS (pH = 7.0) without red wine (B, solid line) or in the presence of
Egri bikavér wine in 25- (B, dashed line) and 250-fold (B, dotted line) final dilution. Spectra were recorded at
3.9 M and 57 g/ml dye and protein concentrations, respectively.
 Changes in the secondary structure of PMS-trypsin were followed by ECD measurements. ECD spectra
of PMS-trypsin in 60% (v/v) ethanol/10 mM PBS (pH = 7.0), measured in the presence or in the absence of 50-
fold diluted Egri bikavér are shown in Figure 5. Measurements were carried out by placing the cuvette either in
the  middle  of  the  sample  compartment  or  next  to  the  detector.  For  clear,  homogenous  samples  the  two
measurements shall provide identical results. Remarkable change in the intensity and a blue shift of the 217 nm
minimum was observed in the absence of red wine, upon moving the cuvette from the middle of the sample
compartment towards the detector, indicating aggregated particles in the sample. Light dispersion of the sample
was significantly decreased by the addition of 50-fold diluted Egri bikavér wine, suggesting that a lower amount
of aggregates is present compared to the sample not containing the additive. It was shown previously, that high
concentrations  of  ethanol  promote  structural  transitions of  PMS-trypsin,  resulting in  an  increase  of  β-sheet
structure of the protein [24]. Such structural features were not changed remarkably by the addition of diluted red
wine. Conversely, ECD spectra recorded in different cuvette positions suggest, that addition of red wine do not
arrest transition from native to β-sheet structure, but it may inhibit intermolecular associations and the formation
of large aggregates.
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Figure 5. ECD spectra of PMS-trypsin in 60% (v/v) ethanol/10 mM PBS (pH = 7.0) in the absence (solid line,
dashed line) and in the presence of 50-fold diluted Egri bikavér (dotted-dashed line, dotted line). The sample was
set  either  in  the middle of  the sample compartment  (solid  line,  dashed-dotted line),  or  next to the detector
(dashed line, dotted line). PMS-trypsin concentration was 0.15 mg/ml.
CONCLUSIONS
Results of the present in vitro study demonstrated that red wines inhibit the aggregation of PMS-trypsin
in 60% (v/v) ethanol/10 mM PBS (pH = 7.0) in a dose-dependent manner. The inhibitory effect was found to
correlate with the amount of natural phenolic and polyphenolic substances contained in red wines. Although
further studies are needed to verify direct applicability of red wine or its active components, our results suggest
that moderate red wine consumption may constitute a part of a preventive dietary strategy against amyloidogenic
diseases of the gastrointestinal tract. Among the examined red wines Egri bikavér demonstrated the strongest
inhibitory effect on trypsin fibril formation.
LIST OF ABBREVIATIONS
BAEE, N-benzoyl-L-arginine ethyl ester; ECD, electronic circular dichroism; CR, Congo red; GAE, gallic acid
equivalent; PBS, phosphate buffered saline; PMSF, phenylmethylsulfonyl fluoride
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